At the present time, 430 drugs are known to cause respiratory injury. This represents an increase of almost 200 in the last ten years, and the number is still increasing. This comprehensive, definitive reference work, with an outstanding range of international expert contributors and two of the world's leading editors, provides an essential referen
GENERAL: Classification, diagnosis, and management of drug-induced respiratory disease. Mechanisms of chemically induced respiratory toxicities. Imaging of drug-induced lung disease. Bronchoalveolar lavage in drug-induced lung disease. Pathology of drug-induced respiratory disease. Drug allergy in lung disease. DRUG-INDUCED RESPIRATORY EMERGENCIES: Drug-induced upper airway obstruction. Drug-induced bronchospasm. Drug-induced pulmonary oedema and acute respiratory distress syndrome. Pulmonary complications of blood transfusion. Drug-induced alveolar haemorrhage. Pulmonary complications of illicit drug use. Iatrogenic tracheobronchial and chest injury. ONCOLOGY AND ALLIED CONDITIONS: Pulmonary reactions to chemotherapeutic agents: The 'chemotherapy lung'. Pulmonary reactions to novel chemotherapeutic agents and biomolecules. Radiation-induced lung disease. Pulmonary complications of bone-marrow and stem-cell transplantation. Pulmonary complications of solid-organ transplantation. Pulmonary infection induced by drugs. Therapy-induced neoplasms. NON-ONCOLOGICAL CONDITIONS: Pneumonitis induced by non-cytotoxic agents. Amiodarone pulmonary toxicity. Eosinophilic pneumonia induced by drugs. Bronchiolitis obliterans organizing pneumonia induced by drugs or radiotherapy. Coughing induced by drugs. Pleural disease induced by drugs. Lupus erythematosus syndrome induced by drugs. Vasculitis induced by drugs. Pulmonary hypertension induced by drugs and toxins. Respiratory involvement from herbals.